By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Verona Pharma 

Suite 21 - Alpha House
100 Borough High Street
London    SE1 1LB  United Kingdom
Phone: 44-0-20-7863-3300 Fax: 44-0-20-7863-3314



Life Sciences

Company News
Verona Pharma (VRP.L) Release; RPL554 Presentation At The Asthma And COPD Conference, London, 14 April 2015 4/14/2015 9:44:19 AM
Verona Pharma (VRP.L) Release: Trading and Development Programme Update 3/3/2015 7:44:58 AM
Verona Pharma (VRP.L) Release: First Patients Successfully Dosed In Clinical Trial With New Commercially Scalable Formulation Of Nebulised RPL554 1/12/2015 11:16:10 AM
Appointment Of Dr Kenneth Newman As Chief Medical Officer And Incorporation Of Verona Pharma (VRP.L) 12/17/2014 10:03:24 AM
Verona Pharma (VRP.L) Release: Appointment Of Dr. David Ebsworth As Non-Executive Chairman Of The Board Of Directors 11/24/2014 11:54:18 AM
Verona Pharma (VRP.L) Announces Venture And Innovation Award From The Cystic Fibrosis Trust 11/3/2014 12:50:50 PM
Verona Pharma (VRP.L) Release: Appointment Of Biresh Roy As CFO And Member Of The Board Of Directors 9/30/2014 9:09:22 AM
Verona Pharma (VRP.L) New Data Supports RPL554 As A Potential Novel Cystic Fibrosis Therapy 9/29/2014 11:08:25 AM
Verona Pharma (VRP.L) Release: Interim Results For The Six Months Ended 30 June 2014 9/11/2014 9:49:14 AM
Verona Pharma (VRP.L) Release: RPL554 Presentations At ERS Congress Highlight Its Valuable Potential In Combination Therapy For COPD And Other Respiratory Diseases 9/9/2014 9:16:58 AM